Skip to main content

TABLE 6.

Comparison of reports on MICs for B. anthracis

Antibiotic Source or reference Test method No. of strains MIC (μg/ml)
Breakpointsa
Interpretation (%)b
Range 50% 90% S (≤) R (≥) Se I R
Amoxycillin-clavulanic This study Etest 45 0.016-0.5 0.032 0.047 4 8 100
    acid This study Agar dilution 10 0.015-0.06 0.03 0.06 100
4 Agar dilution 96 0.125-16 0.125 4 88.5 11.5
10 Agar dilution 22 0.015-0.015 0.015 0.015 100
22 Agar dilution 70 0.03-64 0.125 0.06 99 1
Azithromycin This study Etest 73 1-12 3 6 2 8 26 64 10
Cefotaxime This study Etest 76 3->32 >32 >32 8 64 1 99c
This study Agar dilution 10 16-64 32 32 100
10 Disk diffusion 22 4 14 82
10 Agar dilution 22 8-32 32 32
29 Disk diffusion 44 100
Ciprofloxacin This study Etest 76 0.032-0.094 0.064 0.094 ≤0.5 100
This study Agar dilution 10 0.06 0.06 0.06 100
4 Agar dilution 96 0.03-0.5 0.06 0.25 100
9 Etest 25 0.032-0.38 0.094 0.094 100
10 Agar dilution 22 0.03-0.06 0.03 0.06 100
10 Disk diffusion 22 100
12 Agar dilution 40 <0.008-0.12 0.03 0.06 100
Klugman et al.f NCCLS methods 25 0.0625-0.125 0.0625 0.0625 100
22 Agar dilution 70 0.03-0.06 0.06 0.06 100
26 Agar dilution 65 0.03-0.12 0.06 0.06 100
Brooks et al.d Microdilution 12 <0.25 <0.25 <0.25 100
Erythromycin This study Etest 69 0.5-4 1 1.5 0.5 8 15 85
This study Agar dilution 10 0.5-2 1 2 10 90
4 Agar dilution 96 0.5-4 1 1 95.4 4.6
10 Disk diffusion 22 100
Klugman et al. NCCLS methods 25 0.125-4 0.5 1 NA
22 Agar dilution 70 0.25-1 0.5 1 NA NA 0
26 Agar dilution 65 0.5-1 1 1 3 97
29 Disk diffusion 44 100
Brooks et al. Microdilution 12 0.25-4 0.5 1 8 92
Gentamicin This study Etest 75 0.064-0.5 0.25 0.38 4 16 100
This study Agar dilution 10 0.25-0.5 0.25 0.5 100
4 Agar dilution 96 0.125-0.5 0.25 0.5 100
10 Agar dilution 22 0.03-0.25 0.06 0.125 100
10 Disk diffusion 22 100
22 Agar dilution 70 0.06-0.5 0.125 0.25 100
29 Disk diffusion 44 97.8 2.2
Penicillin This study Etest 74 <0.016->32 <0.016 0.023 0.12 0.25 97 3
This study Agar dilution 8 0.015-0.5 0.015 0.015 e
4 Agar dilution 96 0.125-16 0.125 8 88.5 11.5
9 Etest 25 <0.016-0.5 0.042 0.236 88 12
10 Agar dilution 22 0.015-0.03 0.015 0.015 100
10 Disk diffusion 22 100
12 Agar dilution 40 0.016-0.03 0.016 0.016 100
22 Agar dilution 70 0.015-64 0.06 0.125 99 1
26 Agar dilution 65 <0.06-128 ≤0.06 ≤0.06 97 3
29 Disk diffusion 44 84.1 15.9
Tetracycline This study Etest 71 0.016-0.094 0.023 0.032 1 100
This study Agar dilution 10 0.015-0.06 0.015 0.03 100
10 Disk diffusion 22 100
22 Agar dilution 70 0.6-1 0.125 0.125 100
26 Agar dilution 65 0.03-0.06 0.03 0.06 100
29 Disk diffusion 44 100
Vancomycin This study Etest 74 0.75-5 2 3 4 32 99 1
This study Agar dilution 10 1-4 4 4 100
4 Agar dilution 96 0.25-2 1 1 100
10 Agar dilution 22 0.25-1 1 1 95 5
10 Disk diffusion 22 95 5
26 Agar dilution 65 0.5-2 2 2 100
a

NCCLS MIC interpretive standards (see footnotes to Table 3). Interpretations in the cited reports predate the newly available NCCLS breakpoints for B. anthracis and ciprofloxacin, penicillin, and tetracycline.

b

S, susceptible; I, intermediate; R, resistant; NA, information not available.

c

Resistance inferred. The highest level on the strips used was 32 μg/ml.

d

T. Brooks, P. C. B. Turnbull, and A. Maule, unpublished results.

e

—, for penicillin, ASC 32, ASC 70, and ASC 183 resistant; remainder susceptible.

f

K.P. Klugman, J. Frean, L. Arntzen, V. Yeldandi, and S. Bukofzer, Addendum, Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother., abstr. UL-20, p. 7, 2001.